This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Mar;236(3):861-863.

doi: 10.1007/s00213-018-5112-4. Epub 2018 Nov 10.

A reply to Henningfield, Fant & Wang (2018): regulatory action to control kratom is long overdue

David V Gauvin¹, Zachary J Zimmermann²

Affiliations

Affiliations

¹ Neurobehavioral Sciences Department, Abuse Liability and Ototoxicity, MPI Research (A Charles River Company), 54943 North Main St., Mattawan, MI, 49071, USA. david.gauvin@mpiresearch.com.
² Neurobehavioral Sciences Department, Abuse Liability and Ototoxicity, MPI Research (A Charles River Company), 54943 North Main St., Mattawan, MI, 49071, USA.

PMID: 30415275
DOI: 10.1007/s00213-018-5112-4

Comment

A reply to Henningfield, Fant & Wang (2018): regulatory action to control kratom is long overdue

David V Gauvin et al. Psychopharmacology (Berl). 2019 Mar.

. 2019 Mar;236(3):861-863.

doi: 10.1007/s00213-018-5112-4. Epub 2018 Nov 10.

Authors

David V Gauvin¹, Zachary J Zimmermann²

Affiliations

¹ Neurobehavioral Sciences Department, Abuse Liability and Ototoxicity, MPI Research (A Charles River Company), 54943 North Main St., Mattawan, MI, 49071, USA. david.gauvin@mpiresearch.com.
² Neurobehavioral Sciences Department, Abuse Liability and Ototoxicity, MPI Research (A Charles River Company), 54943 North Main St., Mattawan, MI, 49071, USA.

PMID: 30415275
DOI: 10.1007/s00213-018-5112-4

No abstract available

PubMed Disclaimer

Comment on

The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.
Henningfield JE, Fant RV, Wang DW. Henningfield JE, et al. Psychopharmacology (Berl). 2018 Feb;235(2):573-589. doi: 10.1007/s00213-017-4813-4. Epub 2017 Dec 23. Psychopharmacology (Berl). 2018. PMID: 29273821 Free PMC article. Review.

References

1. J Neonatal Perinatal Med. 2019;12(1):109-112 - PubMed
1. Psychopharmacology (Berl). 2018 Feb;235(2):573-589 - PubMed
1. Neurosci Biobehav Rev. 2013 Feb;37(2):138-51 - PubMed
1. Lancet. 2016 Oct 8;388(10053):1659-1724 - PubMed
1. Chem Pharm Bull (Tokyo). 2004 Aug;52(8):916-28 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer